← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Madeleine Pharmaceuticals, Inc.
Madison, WI
$3,927,918
Total funding
1
Grants
Funding over time
peak $2M · FY2016–22$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,927,918 · 1
By mechanism
R44$3,927,918 · 1
Investigators at Madeleine Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a novel drug treatment for decompensated heart failure.$1,996,767
R44 · FY2016 · HL
A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure$1,044,010
R44 · FY2021 · HL
A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure$887,140
R44 · FY2020 · HL
A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure$1
R44 · FY2022 · HL